Joris Pezzini is Alira Health’s Executive Vice President of Biopharma, overseeing the Biopharma transversal offerings including consulting, transaction advisory, research and clinical development, and Real-World Evidence.

Joris has 20 years of experience in the Biotech and pharma industry, including science and business roles in Biotechs, mid-size pharma, and consulting firms. Before joining Alira Health in 2019, Joris was head of licensing for UCB, a €4B pharma company focusing on neurology, immunology, and rare diseases. He was also executive vice president of strategy and business development at LFB, a €500M plasma derivatives pharma diversifying into cell therapy and recombinant proteins. Joris also spent three years at Bionest Partners as a healthcare strategy consultant and began his career as a Bioprocess scientist in California and the UK.

Joris is a biotechnology engineer and holds a Business and Leadership degree from Harvard Business School.